• Publications
  • Influence
[Reduced-dose adjuvant CMF-chemotherapy combined with postoperative irradiation in breast cancer with lymphatic metastases. A prospective study of 45 patients].
From 1978 to 1982, 45 postoperative cases of breast cancer with lymphatic spread received radiation to the chestwall and axillary, supra- and infraclavicular lymph nodes up to 40 Gy. In addition, weExpand
  • 3
Evolution of the 21-gene Assay Onco type DX ® from an Experimental Assay to an Instrument Assisting in Risk Prediction and Optimisation of Treatment Decision-making in Early Breast Cancer Breast
Decision-making for risk-adapted adjuvant systemic treatment has become a complex process in early breast cancer. In hormone-receptorpositive disease in particular, risk of recurrence and theExpand
  • 1
  • PDF
Versorgung von Mammakarzinompatientinnen
Locoregional intraarterial chemotherapy in primary incurable breast cancer recurrences
SummaryApproximately one third of all local recurrences of breast cancer are incurable at the time of diagnosis. Locoregional intraarterial chemotherapy is one of the new therapy modalities besidesExpand
[Treatment errors in breast surgery from the forensic viewpoint].
Stammzellgestützte Hochdosischemotherapie (HDC) des Ovarialkarzinoms
  • U. Nitz
  • Medicine
  • Der Gynäkologe
  • 27 February 1997
Zum ThemaWegen der hohen Chemotherapiesensibilität der Ovarialkarzinome erscheint eine Verbesserung der Überlebensraten durch hochdosierte Chemotherapeutika möglich. Die Dosiseskalation ist in derExpand
Adjuvante und Neoadjuvante Therapie — Freie Themen